A Critical Review of Animal Models Used in Acute Myeloid Leukemia Pathophysiology
AbstractAcute myeloid leukemia (AML) is one of the most frequent, complex, and heterogeneous hematological malignancies. AML prognosis largely depends on acquired cytogenetic, epigenetic, and molecular abnormalities. Despite the improvement in understanding the biology of AML, survival rates remain quite low. Animal models offer a valuable tool to recapitulate different AML subtypes, and to assess the potential role of novel and known mutations in disease progression. This review provides a comprehensive and critical overview of select available AML animal models. These include the non-mammalian Zebrafish and Drosophila models as well as the mammalian rodent systems, comprising rats and mice. The suitability of each animal model, its contribution to the advancement of knowledge in AML pathophysiology and treatment, as well as its advantages and limitations are discussed. Despite some limitations, animal models represent a powerful approach to assess toxicity, and permit the design of new therapeutic strategies. View Full-Text
Share & Cite This Article
Skayneh, H.; Jishi, B.; Hleihel, R.; Hamieh, M.; Darwiche, N.; Bazarbachi, A.; El Sabban, M.; El Hajj, H. A Critical Review of Animal Models Used in Acute Myeloid Leukemia Pathophysiology. Genes 2019, 10, 614.
Skayneh H, Jishi B, Hleihel R, Hamieh M, Darwiche N, Bazarbachi A, El Sabban M, El Hajj H. A Critical Review of Animal Models Used in Acute Myeloid Leukemia Pathophysiology. Genes. 2019; 10(8):614.Chicago/Turabian Style
Skayneh, Hala; Jishi, Batoul; Hleihel, Rita; Hamieh, Maguy; Darwiche, Nadine; Bazarbachi, Ali; El Sabban, Marwan; El Hajj, Hiba. 2019. "A Critical Review of Animal Models Used in Acute Myeloid Leukemia Pathophysiology." Genes 10, no. 8: 614.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.